Home/Filings/4/0000899243-23-005558
4//SEC Filing

Day Lucy 4

Accession 0000899243-23-005558

CIK 0001880438other

Filed

Feb 16, 7:00 PM ET

Accepted

Feb 17, 7:29 PM ET

Size

5.3 KB

Accession

0000899243-23-005558

Insider Transaction Report

Form 4
Period: 2023-02-15
Day Lucy
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2023-02-15+82,30082,300 total
    Exercise: $14.29Exp: 2033-02-14Common Stock (82,300 underlying)
Footnotes (1)
  • [F1]The shares subject to the option vest as follows: 1/48 of the shares shall vest on each monthly anniversary as measured from January 1, 2023.

Issuer

AN2 Therapeutics, Inc.

CIK 0001880438

Entity typeother

Related Parties

1
  • filerCIK 0001914510

Filing Metadata

Form type
4
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 7:29 PM ET
Size
5.3 KB